Global Plan To End TB Includes Research For New Vaccines

The Guardian: Quest for tuberculosis vaccine begins as scientists aim to beat disease by 2035
“…Despite the [BCG] vaccine’s widespread use, more than nine million people around the world become ill with the disease each year. In 2014, it killed 1.5 million people. … The quest for a new vaccine is at the heart of an ambitious new strategy, introduced last month, to end tuberculosis as a public health threat by 2035. … The new Global Plan to End TB calls for a $56-58bn (£37-38bn) investment in TB programs, alongside $9bn for new research and development, including vaccines…” (Green, 12/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.